Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.

Source:http://linkedlifedata.com/resource/pubmed/id/16012721

Download in:

View as

General Info

PMID
16012721